{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:12:24Z","timestamp":1792019544745,"version":"4.4.0"},"reference-count":137,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T00:00:00Z","timestamp":1734134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical University of Bialystok","award":["B.SUB.24.250"],"award-info":[{"award-number":["B.SUB.24.250"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>The World Health Organization in 2021 ranked Alzheimer\u2019s disease and other dementias as the seventh leading cause of death globally. Neurodegenerative disorders are progressive, intractable, and often fatal diseases. Early diagnosis may allow patients to enjoy prolonged survival with attenuated symptomatology because of early intervention. Hence, further research on finding non-invasive biomarkers of neurodegenerative diseases is warranted. Apolipoprotein D (ApoD) is a glycoprotein involved in lipid metabolism, oxidative stress regulation, and inflammation. It is expressed in various body fluids and regions of the central nervous system. ApoD\u2019s roles in neuroprotection, lipid transport, and anti-inflammatory processes are crucial as far as the prevention of neurodegenerative pathologies is concerned. This review aims to summarize the background knowledge on ApoD, and it covers studies indexed in the PubMed, Scopus, and Web of Science databases. It discusses the evidence for the multifaceted roles of ApoD in the mechanisms and pathogenesis of multiple sclerosis, Alzheimer\u2019s disease, and Parkinson\u2019s disease. ApoD may be a specific, sensitive, easily obtained, cost-effective biomarker for neurodegenerative diseases and its applications in diagnostic practices, treatment strategies, and advancing neurodegenerative disorders\u2019 management.<\/jats:p>","DOI":"10.3390\/diagnostics14242814","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T09:17:58Z","timestamp":1734340678000},"page":"2814","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Role and Diagnostic Significance of Apolipoprotein D in Selected Neurodegenerative Disorders"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0937-2938","authenticated-orcid":false,"given":"Agata","family":"Kolanek","sequence":"first","affiliation":[{"name":"Students\u2019 Scientific Club \u201cBiochemistry of Civilization Diseases\u201d at the Department of Hygiene, Epidemiology and Ergonomics, Medical University of Bialystok, 15-233 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8372-2905","authenticated-orcid":false,"given":"Roman","family":"Cemaga","sequence":"additional","affiliation":[{"name":"Students\u2019 Scientific Club \u201cBiochemistry of Civilization Diseases\u201d at the Department of Hygiene, Epidemiology and Ergonomics, Medical University of Bialystok, 15-233 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5609-3187","authenticated-orcid":false,"given":"Mateusz","family":"Maciejczyk","sequence":"additional","affiliation":[{"name":"Department of Hygiene, Epidemiology and Ergonomics, Medical University of Bialystok, 2c Mickiewicza Street, 15-233 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1474-4422(19)30411-9","article-title":"The global burden of neurological disorders: Translating evidence into policy","volume":"19","author":"Feigin","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.neurobiolaging.2014.01.148","article-title":"Apolipoprotein D takes center stage in the stress response of the aging and degenerative brain","volume":"35","author":"Dassati","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"144874","DOI":"10.1016\/j.gene.2020.144874","article-title":"Apolipoprotein D","volume":"756","author":"Rassart","year":"2020","journal-title":"Gene"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2217\/clp.10.37","article-title":"Apolipoproteins in the brain: Implications for neurological and psychiatric disorders","volume":"5","author":"Elliott","year":"2010","journal-title":"Clin. Lipidol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Wang, Y., Meng, W., Liu, Z., An, Q., and Hu, X. (2022). Cognitive impairment in psychiatric diseases: Biomarkers of diagnosis, treatment, and prevention. Front. Cell. Neurosci., 16.","DOI":"10.3389\/fncel.2022.1046692"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3233\/JAD-160032","article-title":"Apo J and Apo D: Complementary or Antagonistic Roles in Alzheimer\u2019s Disease?","volume":"53","author":"Navarro","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Kim, J., Jeong, M., Stiles, W.R., and Choi, H.S. (2022). Neuroimaging Modalities in Alzheimer\u2019s Disease: Diagnosis and Clinical Features. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23116079"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"502","DOI":"10.34172\/apb.2023.061","article-title":"Tau Protein Biosensors in the Diagnosis of Neurodegenerative Diseases","volume":"13","author":"Sadeghzadeh","year":"2023","journal-title":"Adv. Pharm. Bull."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13195-019-0485-0","article-title":"Advantages and disadvantages of the use of the CSF Amyloid \u03b2 (A\u03b2) 42\/40 ratio in the diagnosis of Alzheimer\u2019s Disease","volume":"11","author":"Hansson","year":"2019","journal-title":"Alzheimers Res. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Yang, J., Hamade, M., Wu, Q., Wang, Q., Axtell, R., Giri, S., and Mao-Draayer, Y. (2022). Current and Future Biomarkers in Multiple Sclerosis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23115877"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41531-022-00357-0","article-title":"Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson\u2019s disease and other synucleinopathies","volume":"8","author":"Lashuel","year":"2022","journal-title":"Npj Park. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Maciejczyk, M., Zalewska, A., and Gerreth, A.K. (2020). Salivary Redox Biomarkers in Selected Neurodegenerative Diseases. J. Clin. Med., 9.","DOI":"10.3390\/jcm9020497"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Luebke, M., Parulekar, M., and Thomas, F.P. (2023). Fluid biomarkers for the diagnosis of neurodegenerative diseases. Biomark. Neuropsychiatry, 8.","DOI":"10.1016\/j.bionps.2023.100062"},{"key":"ref_14","unstructured":"Johnson, L.R. (2006). CHAPTER 60\u2014Gallbladder Function. Physiology of the Gastrointestinal Tract, Academic Press. [4th ed.]."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/01.mol.0000169348.61191.ac","article-title":"Apolipoprotein structure and dynamics","volume":"16","author":"Gursky","year":"2005","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Tao, X., Tao, R., Wang, K., and Wu, L. (2024). Anti-inflammatory mechanism of Apolipoprotein A-I. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1417270"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"949072","DOI":"10.1155\/2011\/949072","article-title":"Cross-Talk between Apolipoprotein E and Cytokines","volume":"2011","author":"Zhang","year":"2011","journal-title":"Mediators Inflamm."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.0910136107","article-title":"Methionine oxidation induces amyloid fibril formation by full-length apolipoprotein A-I","volume":"107","author":"Wong","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/ATVBAHA.110.222000","article-title":"Lipid-Free Apolipoprotein A-I and Discoidal Reconstituted High-Density Lipoproteins Differentially Inhibit Glucose-Induced Oxidative Stress in Human Macrophages","volume":"31","author":"Tabet","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Fyfe-Desmarais, G., Desmarais, F., Rassart, \u00c9., and Mounier, C. (2023). Apolipoprotein D in Oxidative Stress and Inflammation. Antioxid, 12.","DOI":"10.3390\/antiox12051027"},{"key":"ref_21","unstructured":"Devaraj, S., Semaan, J.R., and Jialal, I. (2024). Biochemistry, Apolipoprotein B. StatPearls, StatPearls Publishing."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"He, Y., Chen, J., Ma, Y., and Chen, H. (2022). Apolipoproteins: New players in cancers. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.1051280"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1530-0277.1989.tb00431.x","article-title":"Apolipoprotein AI is a serum and tissue marker of liver fibrosis in alcoholic patients","volume":"13","author":"Bedossa","year":"1989","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1161\/ATVBAHA.123.318267","article-title":"ApoA-I and Diabetes","volume":"43","author":"King","year":"2023","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Del Valle, E., Rubio-Sard\u00f3n, N., Men\u00e9ndez-P\u00e9rez, C., Mart\u00ednez-Pinilla, E., and Navarro, A. (2023). Apolipoprotein D as a Potential Biomarker in Neuropsychiatric Disorders. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242115631"},{"key":"ref_26","first-page":"122","article-title":"Role of Apolipoproteins in Neurodegenerative Diseases","volume":"5","author":"Elmas","year":"2023","journal-title":"J. Gazi Univ. Health Sci. Inst."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Sanchez, D., and Ganfornina, M.D. (2021). The Lipocalin Apolipoprotein D Functional Portrait: A Systematic Review. Front. Physiol., 12.","DOI":"10.3389\/fphys.2021.738991"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/0014-5793(73)80453-3","article-title":"Isolation and partial characterization of apolipoprotein D: A new protein moiety of the human plasma lipoprotein system","volume":"37","author":"McConathy","year":"1973","journal-title":"FEBS Lett."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1021\/bi00648a010","article-title":"Studies on the isolation and partial characterization of apolipoprotein D and lipoprotein D of human plasma","volume":"15","author":"McConathy","year":"1976","journal-title":"Biochemistry"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.18632\/aging.100004","article-title":"Apolipoprotein D in lipid metabolism and its functional implication in atherosclerosis and aging","volume":"1","author":"Perdomo","year":"2009","journal-title":"Aging"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1089\/dna.1987.6.199","article-title":"Human Apolipoprotein D Gene: Gene Sequence, Chromosome Localization, and Homology to the \u03b12u-Globulin Superfamily","volume":"6","author":"Drayna","year":"1987","journal-title":"DNA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0167-4781(93)90292-L","article-title":"Structure of the human apolipoprotein D gene promoter region","volume":"1172","author":"Lambert","year":"1993","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.bbamcr.2007.03.007","article-title":"Modulation of apolipoprotein D expression and translocation under specific stress conditions","volume":"1773","author":"Levros","year":"2007","journal-title":"Biochim. Biophys. Acta BBA Mol. Cell Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1194\/jlr.M300312-JLR200","article-title":"Liver X receptors are regulators of adipocyte gene expression but not differentiation: Identification of apoD as a direct target","volume":"45","author":"Hummasti","year":"2004","journal-title":"J. Lipid Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"16535","DOI":"10.1016\/S0021-9258(18)66599-8","article-title":"Cloning and expression of human apolipoprotein D cDNA","volume":"261","author":"Drayna","year":"1986","journal-title":"J. Biol. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0022-2275(20)42739-7","article-title":"Cellular localization of apolipoprotein D and lecithin:cholesterol acyltransferase mRNA in rhesus monkey tissues by in situ hybridization","volume":"31","author":"Smith","year":"1990","journal-title":"J. Lipid Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/S0022-2275(20)41899-1","article-title":"Localization of the major sites of rabbit apolipoprotein D gene transcription by in situ hybridization","volume":"32","author":"Provost","year":"1991","journal-title":"J. Lipid Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1073\/pnas.071056198","article-title":"Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: Implications for the pathophysiology of psychiatric disorders","volume":"98","author":"Thomas","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1471-4159.2009.06031.x","article-title":"Apolipoprotein-D expression is increased during development and maturation of the human prefrontal cortex","volume":"109","author":"Kim","year":"2009","journal-title":"J. Neurochem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/nan.12595","article-title":"Apolipoprotein D: A potential biomarker for cerebral amyloid angiopathy","volume":"46","author":"Kuiperij","year":"2020","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1023993405851","article-title":"Apolipoprotein D in the Niemann-Pick type C disease mouse brain: An ultrastructural immunocytochemical analysis","volume":"31","author":"Ong","year":"2002","journal-title":"J. Neurocytol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0005-2760(94)00232-N","article-title":"Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluid","volume":"1255","author":"Borghini","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0167-4838(97)00198-2","article-title":"AP30, a differential protein marker for perilymph and cerebrospinal fluid in middle ear fluid, has been purified and identified as human apolipoprotein D","volume":"1384","author":"Sun","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/elps.1150110119","article-title":"Identification and quantification of apolipoprotein D in normal human urine","volume":"11","author":"Holmquist","year":"1990","journal-title":"Electrophoresis"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"6626","DOI":"10.1073\/pnas.93.13.6626","article-title":"A human axillary odorant is carried by apolipoprotein D","volume":"93","author":"Zeng","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0014-4835(05)80145-9","article-title":"The human lacrimal gland synthesizes apolipoprotein D mRNA in addition to tear prealbumin mRNA, both species encoding members of the lipocalin superfamily","volume":"61","author":"Holzfeind","year":"1995","journal-title":"Exp. Eye Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1042\/bj2710803","article-title":"Apolipoprotein D is the major protein component in cyst fluid from women with human breast gross cystic disease","volume":"271","author":"Freije","year":"1990","journal-title":"Biochem. J."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"31068","DOI":"10.1074\/jbc.M703552200","article-title":"Structural insight into the dual ligand specificity and mode of high density lipoprotein association of apolipoprotein D","volume":"282","author":"Eichinger","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Qin, Y., Chen, Y., Yang, J., Wu, F., Zhao, L., Yang, F., Xue, P., Shi, Z., Song, T., and Huang, C. (2017). Serum glycopattern and Maackia amurensis lectin-II binding glycoproteins in autism spectrum disorder. Sci. Rep., 7.","DOI":"10.1038\/srep46041"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Li, H., Ruberu, K., Karl, T., and Garner, B. (2016). Cerebral Apolipoprotein-D Is Hypoglycosylated Compared to Peripheral Tissues and Is Variably Expressed in Mouse and Human Brain Regions. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0148238"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e17478","DOI":"10.1097\/MD.0000000000017478","article-title":"Differential proteomic analysis of serum exosomes reveals alterations in progression of Parkinson disease","volume":"98","author":"Jiang","year":"2019","journal-title":"Medicine"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Stoop, M.P., Singh, V., Dekker, L.J., Titulaer, M.K., Stingl, C., Burgers, P.C., Sillevis Smitt, P.A.E., Hintzen, R.Q., and Luider, T.M. (2010). Proteomics Comparison of Cerebrospinal Fluid of Relapsing Remitting and Primary Progressive Multiple Sclerosis. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0012442"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.neurobiolaging.2013.08.027","article-title":"Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults","volume":"35","author":"Mattsson","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"ref_54","first-page":"3751516","article-title":"Apolipoprotein D Concentration in Human Plasma during Aging and in Parkinson\u2019s Disease: A Cross-Sectional Study","volume":"2018","author":"Waldner","year":"2018","journal-title":"Park. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000509561","article-title":"Urinary Apolipoprotein C3 Is a Potential Biomarker for Alzheimer\u2019s Disease","volume":"10","author":"Watanabe","year":"2020","journal-title":"Dement. Geriatr. Cogn. Disord. Extra"},{"key":"ref_56","first-page":"e12231","article-title":"Effect of APOE \u03b54 allele on levels of apolipoproteins E, J, and D, and redox signature in circulating extracellular vesicles from cognitively impaired with no dementia participants converted to Alzheimer\u2019s disease","volume":"13","author":"Haddad","year":"2021","journal-title":"Alzheimers Dement. Diagn. Assess. Dis. Monit."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.3233\/JAD-140141","article-title":"Proteomic Analysis of Cerebrospinal Fluid in Alzheimer\u2019s Disease: Wanted Dead or Alive","volume":"44","author":"Zvara","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/glia.21010","article-title":"ApoD, a glia-derived apolipoprotein, is required for peripheral nerve functional integrity and a timely response to injury","volume":"58","author":"Ganfornina","year":"2010","journal-title":"Glia"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1093\/brain\/awf230","article-title":"PMP22 overexpression causes dysmyelination in mice","volume":"125","year":"2002","journal-title":"Brain"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"17805","DOI":"10.1016\/S0021-9258(18)38235-8","article-title":"Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve. Identification of apolipoprotein D, apolipoprotein A-IV, apolipoprotein E, and apolipoprotein A-I","volume":"265","author":"Boyles","year":"1990","journal-title":"J. Biol. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1002\/j.1460-2075.1990.tb07426.x","article-title":"Regeneration-associated high level expression of apolipoprotein D mRNA in endoneurial fibroblasts of peripheral nerve","volume":"9","author":"Spreyer","year":"1990","journal-title":"EMBO J."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Mateo, N., Ganfornina, M.D., Montero, O., Gij\u00f3n, M.A., Murphy, R.C., and Sanchez, D. (2014). Schwann cell-derived Apolipoprotein D controls the dynamics of post-injury myelin recognition and degradation. Front. Cell. Neurosci., 8.","DOI":"10.3389\/fncel.2014.00374"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000535960","article-title":"Prevalence, Incidence, and Mortality of Multiple Sclerosis in Coimbra, Portugal","volume":"58","author":"Correia","year":"2024","journal-title":"Neuroepidemiology"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Juchnowicz, D., Dzikowski, M., Rog, J., Waszkiewicz, N., Karaku\u0142a, K.H., Zalewska, A., Maciejczyk, M., and Karakula-Juchnowicz, H. (2023). The usefulness of a complete blood count in the prediction of the first episode of schizophrenia diagnosis and its relationship with oxidative stress. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0292756"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Collins, A.E., Saleh, T.M., and Kalisch, B.E. (2022). Naturally Occurring Antioxidant Therapy in Alzheimer\u2019s Disease. Antioxidants, 11.","DOI":"10.3390\/antiox11020213"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Scarf\u00f2, G., Piccarducci, R., Daniele, S., Franzoni, F., and Martini, C. (2022). Exploring the Role of Lipid-Binding Proteins and Oxidative Stress in Neurodegenerative Disorders: A Focus on the Neuroprotective Effects of Nutraceutical Supplementation and Physical Exercise. Antioxidants, 11.","DOI":"10.3390\/antiox11112116"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"15036","DOI":"10.1073\/pnas.93.26.15036","article-title":"Methionine residues as endogenous antioxidants in proteins","volume":"93","author":"Levine","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1042\/BJ20111166","article-title":"Selective reduction of hydroperoxyeicosatetraenoic acids to their hydroxy derivatives by apolipoprotein D: Implications for lipid antioxidant activity and Alzheimer\u2019s disease","volume":"442","author":"Bhatia","year":"2012","journal-title":"Biochem. J."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3233\/JAD-122278","article-title":"Increased Apolipoprotein D Dimer Formation in Alzheimer\u2019s Disease Hippocampus is Associated with Lipid Conjugated Diene Levels","volume":"35","author":"Bhatia","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1474-9726.2008.00395.x","article-title":"Apolipoprotein D is involved in the mechanisms regulating protection from oxidative stress","volume":"7","author":"Ganfornina","year":"2008","journal-title":"Aging Cell"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Pascua-Maestro, R., Gonz\u00e1lez, E., Lillo, C., Ganfornina, M.D., Falc\u00f3n-P\u00e9rez, J.M., and Sanchez, D. (2019). Extracellular Vesicles Secreted by Astroglial Cells Transport Apolipoprotein D to Neurons and Mediate Neuronal Survival Upon Oxidative Stress. Front. Cell. Neurosci., 12.","DOI":"10.3389\/fncel.2018.00526"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00415-004-0470-8","article-title":"Genetic variation in apolipoprotein D and Alzheimer\u2019s disease","volume":"251","author":"Helisalmi","year":"2004","journal-title":"J. Neurol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/0005-2760(88)90235-4","article-title":"Activation of lecithin-cholesterol acyltransferase by apolipoprotein D: Comparison of proteoliposomes containing apolipoprotein D, A-I or C-I","volume":"958","author":"Steyrer","year":"1988","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1194\/jlr.M001206","article-title":"A role of apolipoprotein D in triglyceride metabolism","volume":"51","author":"Perdomo","year":"2010","journal-title":"J. Lipid Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.metabol.2011.04.013","article-title":"Genetic deficiency of apolipoprotein D in the mouse is associated with nonfasting hypertriglyceridemia and hyperinsulinemia","volume":"60","author":"Ganfornina","year":"2011","journal-title":"Metabolism"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0021-9150(02)00012-6","article-title":"Genetic variation in the apolipoprotein D gene among African blacks and its significance in lipid metabolism","volume":"163","author":"Desai","year":"2002","journal-title":"Atherosclerosis"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.atherosclerosis.2021.12.011","article-title":"Elevated levels of apolipoprotein D predict poor outcome in patients with suspected or established coronary artery disease","volume":"341","author":"Annema","year":"2022","journal-title":"Atherosclerosis"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/sj.jcbfm.9600552","article-title":"Apolipoprotein D is Elevated in Oligodendrocytes in the Peri-Infarct Region after Experimental Stroke: Influence of Enriched Environment","volume":"28","author":"Rickhag","year":"2008","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"10330","DOI":"10.1523\/JNEUROSCI.2644-08.2008","article-title":"Neuroprotective Effect of Apolipoprotein D against Human Coronavirus OC43-Induced Encephalitis in Mice","volume":"28","author":"Jacomy","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00011-022-01679-8","article-title":"Apolipoprotein D modulates lipid mediators and osteopontin in an anti-inflammatory direction","volume":"72","author":"Kurano","year":"2023","journal-title":"Inflamm. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1017\/S0029665112000067","article-title":"Long-chain fatty acids and inflammation","volume":"71","author":"Calder","year":"2012","journal-title":"Proc. Nutr. Soc."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.plefa.2003.08.014","article-title":"Apolipoprotein D modulates arachidonic acid signaling in cultured cells: Implications for psychiatric disorders","volume":"69","author":"Thomas","year":"2003","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1007\/s12035-016-9920-4","article-title":"Apolipoprotein D Overexpression Protects Against Kainate-Induced Neurotoxicity in Mice","volume":"54","author":"Najyb","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"ref_84","first-page":"136","article-title":"Role of pro-inflammatory cytokines released from microglia in Alzheimer\u2019s disease","volume":"3","author":"Wang","year":"2015","journal-title":"Ann. Transl. Med."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Corraliza-Gomez, M., Bendito, B., Sandonis-Camarero, D., Mondejar-Duran, J., Villa, M., Poncela, M., Valero, J., Sanchez, D., and Ganfornina, M.D. (2023). Dual role of Apolipoprotein D as long-term instructive factor and acute signal conditioning microglial secretory and phagocytic responses. Front. Cell. Neurosci., 17.","DOI":"10.3389\/fncel.2023.1112930"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/imm.12922","article-title":"Inflammation in CNS neurodegenerative diseases","volume":"154","author":"Stephenson","year":"2018","journal-title":"Immunology"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.4103\/0366-6999.217092","article-title":"Relationship between Apolipoprotein Superfamily and Parkinson\u2019s Disease","volume":"130","author":"Li","year":"2017","journal-title":"Chin. Med. J."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson\u2019s disease","volume":"20","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.neulet.2014.02.053","article-title":"Ropinirole treatment in Parkinson\u2019s disease associated with higher serum level of inflammatory biomarker NT-proCNP","volume":"566","author":"Tomasiuk","year":"2014","journal-title":"Neurosci. Lett."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/mds.26431","article-title":"MDS research criteria for prodromal Parkinson\u2019s disease","volume":"30","author":"Berg","year":"2015","journal-title":"Mov. Disord."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.amjmed.2019.03.001","article-title":"Parkinson\u2019s Disease and Parkinsonism","volume":"132","author":"Hayes","year":"2019","journal-title":"Am. J. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.neulet.2018.06.031","article-title":"Higher serum levels of pro-hepcidin in patients with Parkinson\u2019s disease treated with deep brain stimulation","volume":"684","author":"Geremek","year":"2018","journal-title":"Neurosci. Lett."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Hwang, K.S., Langley, J., Tripathi, R., Hu, X.P., and Huddleston, D.E. (2023). In vivo detection of substantia nigra and locus coeruleus volume loss in Parkinson\u2019s disease using neuromelanin-sensitive MRI: Replication in two cohorts. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0282684"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","article-title":"Parkinson\u2019s disease: Etiopathogenesis and treatment","volume":"91","author":"Jankovic","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4161\/cc.9.2.10433","article-title":"Apolipoprotein D: An overview of its role in aging and age-related diseases","volume":"9","author":"Muffat","year":"2010","journal-title":"Cell Cycle"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/jn\/134.3.489","article-title":"Glutathione metabolism and its implications for health","volume":"134","author":"Wu","year":"2004","journal-title":"J. Nutr."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Maciejczyk, M., \u017bebrowska, E., and Chabowski, A. (2019). Insulin Resistance and Oxidative Stress in the Brain: What\u2019s New?. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20040874"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"111942","DOI":"10.1016\/j.nut.2022.111942","article-title":"Lipid peroxidation and sphingolipid alterations in the cerebral cortex and hypothalamus of rats fed a high-protein diet","volume":"107","author":"Supruniuk","year":"2023","journal-title":"Nutrition"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"(2023). 2023 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. J. Alzheimers Assoc., 19, 1598\u20131695.","DOI":"10.1002\/alz.13016"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/brain\/awx320","article-title":"Widespread brain tau and its association with ageing, Braak stage and Alzheimer\u2019s dementia","volume":"141","author":"Lowe","year":"2018","journal-title":"Brain J. Neurol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13024-022-00574-4","article-title":"ApoE in Alzheimer\u2019s disease: Pathophysiology and therapeutic strategies","volume":"17","author":"Raulin","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.2174\/1567205013666160401115127","article-title":"Alzheimer\u2019s Disease Genetic Risk Factor APOE-\u03b54 Also Affects Normal Brain Function","volume":"13","author":"Heinsinger","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000095740","article-title":"Analysis of the association between Apolipoprotein D and schizophrenia","volume":"54","author":"Zhang","year":"2006","journal-title":"Neuropsychobiology"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.brainres.2008.07.018","article-title":"Association between polymorphisms in the apolipoprotein D gene and sporadic Alzheimer\u2019s disease","volume":"1233","author":"Chen","year":"2008","journal-title":"Brain Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/sj.mp.4001223","article-title":"Differences in neuroanatomical sites of apoD elevation discriminate between schizophrenia and bipolar disorder","volume":"8","author":"Thomas","year":"2003","journal-title":"Mol. Psychiatry"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"408","DOI":"10.2174\/1566524033479681","article-title":"From pharmacotherapy to pathophysiology: Emerging mechanisms of apolipoprotein D in psychiatric disorders","volume":"3","author":"Thomas","year":"2003","journal-title":"Curr. Mol. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12031-018-1217-9","article-title":"Apolipoprotein D Upregulation in Alzheimer\u2019s Disease but Not Frontotemporal Dementia","volume":"67","author":"Bhatia","year":"2019","journal-title":"J. Mol. Neurosci."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.neurobiolaging.2015.02.010","article-title":"Apolipoprotein D modulates amyloid pathology in APP\/PS1 Alzheimer\u2019s disease mice","volume":"36","author":"Li","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Navarro, A., Rioseras, B., Del Valle, E., Mart\u00ednez-Pinilla, E., Astudillo, A., and Tolivia, J. (2018). Expression Pattern of Myelin-Related Apolipoprotein D in Human Multiple Sclerosis Lesions. Front. Aging Neurosci., 10.","DOI":"10.3389\/fnagi.2018.00254"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri3871","article-title":"Immunopathology of multiple sclerosis","volume":"15","author":"Dendrou","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1001\/archneur.61.10.1613","article-title":"Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease","volume":"61","author":"Weiner","year":"2004","journal-title":"Arch. Neurol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/archneur.61.10.1615","article-title":"Is multiple sclerosis an autoimmune disorder?","volume":"61","author":"Roach","year":"2004","journal-title":"Arch. Neurol."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Tarlinton, R.E., Martynova, E., Rizvanov, A.A., Khaiboullina, S., and Verma, S. (2020). Role of Viruses in the Pathogenesis of Multiple Sclerosis. Viruses, 12.","DOI":"10.3390\/v12060643"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.cell.2020.09.054","article-title":"HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis","volume":"183","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMcibr2032177","article-title":"Antigen Presentation by B Cells in Multiple Sclerosis","volume":"384","author":"Zamvil","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Liu, R., Du, S., Zhao, L., Jain, S., Sahay, K., Rizvanov, A., Lezhnyova, V., Khaibullin, T., Martynova, E., and Khaiboullina, S. (2022). Autoreactive lymphocytes in multiple sclerosis: Pathogenesis and treatment target. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.996469"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/pmic.200700446","article-title":"Multiple sclerosis-related proteins identified in cerebrospinal fluid by advanced mass spectrometry","volume":"8","author":"Stoop","year":"2008","journal-title":"Proteomics"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Pinilla, E., Rubio-Sard\u00f3n, N., Pel\u00e1ez, R., Garc\u00eda-\u00c1lvarez, E., Del Valle, E., Tolivia, J., Larr\u00e1yoz, I.M., and Navarro, A. (2021). Neuroprotective Effect of Apolipoprotein D in Cuprizone-Induced Cell Line Models: A Potential Therapeutic Approach for Multiple Sclerosis and Demyelinating Diseases. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22031260"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/mds.28362","article-title":"Novel Protein Biomarkers of Monoamine Metabolism Defects Correlate with Disease Severity","volume":"36","author":"Wassenberg","year":"2021","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bios.2018.09.002","article-title":"Clinical implications and electrochemical biosensing of monoamine neurotransmitters in body fluids, in vitro, in vivo, and ex vivo models","volume":"121","author":"Baranwal","year":"2018","journal-title":"Biosens. Bioelectron."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/bpa.12370","article-title":"Alpha-Synuclein as a Biomarker for Parkinson\u2019s Disease","volume":"26","author":"Atik","year":"2016","journal-title":"Brain Pathol."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Du, T., Wang, L., Liu, W., Zhu, G., Chen, Y., and Zhang, J. (2021). Biomarkers and the Role of \u03b1-Synuclein in Parkinson\u2019s Disease. Front. Aging Neurosci., 13.","DOI":"10.3389\/fnagi.2021.645996"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Constantinides, V.C., Paraskevas, G.P., Boufidou, F., Bourbouli, M., Pyrgelis, E.-S., Stefanis, L., and Kapaki, E. (2023). CSF A\u03b242 and A\u03b242\/A\u03b240 Ratio in Alzheimer\u2019s Disease and Frontotemporal Dementias. Diagnostics, 13.","DOI":"10.3390\/diagnostics13040783"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/01616412.2000.11740678","article-title":"Apolipoprotein D in the aging brain and in Alzheimer\u2019s dementia","volume":"22","author":"Kalman","year":"2000","journal-title":"Neurol. Res."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3233\/JAD-130215","article-title":"Oxidative stress induces apolipoprotein D overexpression in hippocampus during aging and Alzheimer\u2019s disease","volume":"36","author":"Navarro","year":"2013","journal-title":"J. Alzheimers Dis. JAD"},{"key":"ref_127","first-page":"433.e11-20","article-title":"Gender differences in apolipoprotein D expression during aging and in Alzheimer disease","volume":"33","author":"Navarro","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Lacar, B., Ferdosi, S., Alavi, A., Stukalov, A., Venkataraman, G.R., De Geus, M., Dodge, H., Wu, C.-Y., Kivisakk, P., and Das, S. (2024). Identification of Novel Biomarkers for Alzheimer\u2019s Disease and Related Dementias Using Unbiased Plasma Proteomics. bioRxiv.","DOI":"10.1101\/2024.01.05.574446"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1046\/j.1471-4159.1998.71041643.x","article-title":"Increased Levels of Apolipoprotein D in Cerebrospinal Fluid and Hippocampus of Alzheimer\u2019s Patients","volume":"71","author":"Terrisse","year":"1998","journal-title":"J. Neurochem."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1001\/archneurol.2012.1070","article-title":"Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease","volume":"69","author":"Soares","year":"2012","journal-title":"Arch. Neurol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3233\/JAD-230837","article-title":"Comparison of Commonly Measured Plasma and Cerebrospinal Fluid Proteins and Their Significance for the Characterization of Cognitive Impairment Status","volume":"97","author":"Rehman","year":"2024","journal-title":"J. Alzheimers Dis. JAD"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.3233\/JAD-231003","article-title":"Contactin 5 and Apolipoproteins Interplay in Alzheimer\u2019s Disease","volume":"98","author":"Dauar","year":"2024","journal-title":"J. Alzheimers Dis. JAD"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s12031-018-1220-1","article-title":"The Challenge to Search for New Nervous System Disease Biomarker Candidates: The Opportunity to Use the Proteogenomics Approach","volume":"67","author":"Nery","year":"2019","journal-title":"J. Mol. Neurosci."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0165-5728(01)00378-2","article-title":"Increased intrathecal production of apolipoprotein D in multiple sclerosis","volume":"119","author":"Reindl","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/ane.12029","article-title":"Cerebrospinal fluid proteome comparison between multiple sclerosis patients and controls","volume":"126","author":"Kroksveen","year":"2012","journal-title":"Acta Neurol. Scand."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jprot.2012.09.037","article-title":"Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRM","volume":"78","author":"Kroksveen","year":"2013","journal-title":"J. Proteomics"},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Zhao, X., and Jacob, C. (2023). Mechanisms of Demyelination and Remyelination Strategies for Multiple Sclerosis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24076373"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/14\/24\/2814\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:55:16Z","timestamp":1760115316000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/14\/24\/2814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,14]]},"references-count":137,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["diagnostics14242814"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics14242814","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,14]]}}}